2013
DOI: 10.1038/nature12782
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Plasmodium PI(4)K to eliminate malaria

Abstract: SummaryAchieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages. Here, we identify a lipid kinase, phosphatidylinositol 4-kinase (PI4K), as the target of imidazopyrazines, a novel antimalarial compound class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host. Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria mode… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

19
452
1
5

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 384 publications
(477 citation statements)
references
References 47 publications
19
452
1
5
Order By: Relevance
“…7(B,C)]. The compound BQR695 is a recently reported highly potent PI4KIIIβ inhibitor that has high potency against both the human (IC50 = 80 n M ) and Plasmodium vivax (∼3.5 n M ) variants of PI4KIIIβ 26. The binding mode of this compound was unambiguous (Supporting Information Fig.…”
Section: Resultsmentioning
confidence: 97%
See 1 more Smart Citation
“…7(B,C)]. The compound BQR695 is a recently reported highly potent PI4KIIIβ inhibitor that has high potency against both the human (IC50 = 80 n M ) and Plasmodium vivax (∼3.5 n M ) variants of PI4KIIIβ 26. The binding mode of this compound was unambiguous (Supporting Information Fig.…”
Section: Resultsmentioning
confidence: 97%
“…Herein we describe an experimental approach to use HDX‐MS to define dynamic regions within a protein complex, in this case the type III phosphatidylinositol 4 kinase beta (PI4KIIIβ) in complex with the GTPase Rab11, and use this information to generate optimized constructs for X‐ray crystallography. PI4KIIIβ is a lipid kinase that plays a key role in mediating membrane trafficking,21 and is also an emerging drug target for both antiviral22, 23, 24, 25 and antimalarial therapeutics 26. The combined HDX‐MS and X‐ray crystallographic analysis reveals novel aspects of the PI4KIIIβ‐Rab11 complex, specifically conformational changes induced in the switch regions of activated Rab11, as well as novel molecular details of PI4K inhibitor interactions.…”
Section: Introductionmentioning
confidence: 99%
“…Our in silico studies lead to the identification of proteins containing PIPbinding FYVE (22) or PH domains 6 . One of the PH domaincontaining proteins possessed a protein kinase domain and an N-terminal EF-hand calcium-binding motif (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, PF3D7_1129600 catalyzes the phosphorylation of phosphatidylinositol 4-phosphate to form phosphatidylinositol 4,5-bisphosphate (30). The drug target PI(4)K (PF3D7_0509800) alters the intracellular distribution of phosphatidylinositol-4-phosphate in the parasite, placing these genes on the same biologic pathway (31). Although the functional significance of this signal is unclear, genome scans in other populations also have identified strong directional selection at this locus (27,32).…”
Section: P Vivax Shows Stronger Evidence Of Recent Directional Selecmentioning
confidence: 99%